These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 30796972

  • 1. Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells.
    Ko JC, Chen JC, Chen TY, Yen TC, Ma PF, Lin YC, Wu CH, Peng YS, Zheng HY, Lin YW.
    Toxicology; 2019 Apr 01; 417():54-63. PubMed ID: 30796972
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH, Tseng SC, Huang YC, Chen HJ, Lin YW.
    Biochem Pharmacol; 2012 Jul 01; 84(1):126-36. PubMed ID: 22480737
    [Abstract] [Full Text] [Related]

  • 3. Heat shock protein 90 inhibitor 17-AAG down-regulates thymidine phosphorylase expression and potentiates the cytotoxic effect of tamoxifen and erlotinib in human lung squamous carcinoma cells.
    Ko JC, Chen JC, Hsieh JM, Tseng PY, Chiang CS, Liu LL, Chien CC, Huang IH, Chang QZ, Mu BC, Lin YW.
    Biochem Pharmacol; 2022 Oct 01; 204():115207. PubMed ID: 35961402
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells.
    Ko JC, Chiu HC, Syu JJ, Jian YJ, Chen CY, Jian YT, Huang YJ, Wo TY, Lin YW.
    Biochem Pharmacol; 2014 Mar 01; 88(1):119-27. PubMed ID: 24447935
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of MSH2 expression by an Hsp90 inhibitor enhances pemetrexed-induced cytotoxicity in human non-small-cell lung cancer cells.
    Tung CL, Chiu HC, Jian YJ, Jian YT, Chen CY, Syu JJ, Wo TY, Huang YJ, Tseng SC, Lin YW.
    Exp Cell Res; 2014 Apr 01; 322(2):345-54. PubMed ID: 24530475
    [Abstract] [Full Text] [Related]

  • 6. Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells.
    Ko JC, Tsai MS, Chiu YF, Weng SH, Kuo YH, Lin YW.
    J Pharmacol Exp Ther; 2011 Jul 01; 338(1):184-94. PubMed ID: 21444628
    [Abstract] [Full Text] [Related]

  • 7. Salinomycin acts through reducing AKT-dependent thymidylate synthase expression to enhance erlotinib-induced cytotoxicity in human lung cancer cells.
    Tung CL, Chen JC, Wu CH, Peng YS, Chen WC, Zheng HY, Jian YJ, Wei CL, Cheng YT, Lin YW.
    Exp Cell Res; 2017 Aug 01; 357(1):59-66. PubMed ID: 28454878
    [Abstract] [Full Text] [Related]

  • 8. Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression.
    Ko JC, Zheng HY, Chen WC, Peng YS, Wu CH, Wei CL, Chen JC, Lin YW.
    Biochem Pharmacol; 2016 Dec 15; 122():90-98. PubMed ID: 27666600
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
    Tsai MS, Weng SH, Chen HJ, Chiu YF, Huang YC, Tseng SC, Kuo YH, Lin YW.
    Mol Cancer Ther; 2012 Mar 15; 11(3):561-71. PubMed ID: 22053010
    [Abstract] [Full Text] [Related]

  • 10. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
    Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW.
    Regul Toxicol Pharmacol; 2012 Dec 15; 64(3):415-24. PubMed ID: 23069143
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of mitomycin C-induced cytotoxicity by curcumin results from down-regulation of MKK1/2-ERK1/2-mediated thymidine phosphorylase expression.
    Weng SH, Tsai MS, Chiu YF, Kuo YH, Chen HJ, Lin YW.
    Basic Clin Pharmacol Toxicol; 2012 Mar 15; 110(3):298-306. PubMed ID: 21973306
    [Abstract] [Full Text] [Related]

  • 12. Thymidine phosphorylase influences [(18)F]fluorothymidine uptake in cancer cells and patients with non-small cell lung cancer.
    Lee SJ, Yeo JS, Lee HJ, Lee EJ, Kim SY, Jang SJ, Lee JJ, Ryu JS, Moon DH.
    Eur J Nucl Med Mol Imaging; 2014 Jul 15; 41(7):1327-35. PubMed ID: 24562648
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Syu JJ, Wang TJ, Chang PY, Chen CY, Jian YT, Lin YW.
    Exp Cell Res; 2015 May 15; 334(1):126-35. PubMed ID: 25662161
    [Abstract] [Full Text] [Related]

  • 14. Metformin induces cytotoxicity by down-regulating thymidine phosphorylase and excision repair cross-complementation 1 expression in non-small cell lung cancer cells.
    Ko JC, Huang YC, Chen HJ, Tseng SC, Chiu HC, Wo TY, Huang YJ, Weng SH, Chiou RY, Lin YW.
    Basic Clin Pharmacol Toxicol; 2013 Jul 15; 113(1):56-65. PubMed ID: 23362830
    [Abstract] [Full Text] [Related]

  • 15. Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Tung CL, Jian YJ, Chen JC, Wang TJ, Chen WC, Zheng HY, Chang PY, Liao KS, Lin YW.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 15; 389(6):657-66. PubMed ID: 27026405
    [Abstract] [Full Text] [Related]

  • 16. 17-(Allylamino)-17-Demethoxygeldanamycin Enhances Etoposide-Induced Cytotoxicity via the Downregulation of Xeroderma Pigmentosum Complementation Group C Expression in Human Lung Squamous Cell Carcinoma Cells.
    Chen JC, Ma PF, Lin YC, Wu CH, Peng YS, Zheng HY, Lin MC, Li YT, Lin YW.
    Pharmacology; 2018 Jun 15; 102(1-2):91-104. PubMed ID: 29953987
    [Abstract] [Full Text] [Related]

  • 17. Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells.
    Chen RS, Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Chen HJ, Huang YC, Jian YJ, Lee WT, Lin YW.
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec 15; 386(12):1047-59. PubMed ID: 23912706
    [Abstract] [Full Text] [Related]

  • 18. Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine.
    Ko JC, Tsai MS, Kuo YH, Chiu YF, Weng SH, Su YC, Lin YW.
    Biochem Pharmacol; 2011 Mar 01; 81(5):680-90. PubMed ID: 21168393
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of p38 MAPK-dependent MutS homologue-2 (MSH2) expression by metformin enhances gefitinib-induced cytotoxicity in human squamous lung cancer cells.
    Ko JC, Chiu HC, Wo TY, Huang YJ, Tseng SC, Huang YC, Chen HJ, Syu JJ, Chen CY, Jian YT, Jian YJ, Lin YW.
    Lung Cancer; 2013 Dec 01; 82(3):397-406. PubMed ID: 24138903
    [Abstract] [Full Text] [Related]

  • 20. Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinoma.
    Sato J, Sata M, Nakamura H, Inoue S, Wada T, Takabatake N, Otake K, Tomoike H, Kubota I.
    Int J Cancer; 2003 Oct 10; 106(6):863-70. PubMed ID: 12918063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.